Viewing Study NCT04191304


Ignite Creation Date: 2025-12-24 @ 7:59 PM
Ignite Modification Date: 2025-12-25 @ 5:33 PM
Study NCT ID: NCT04191304
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-26
First Post: 2019-11-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module